Institution
VA Palo Alto Healthcare System
Healthcare•Palo Alto, California, United States•
About: VA Palo Alto Healthcare System is a healthcare organization based out in Palo Alto, California, United States. It is known for research contribution in the topics: Population & Health care. The organization has 2548 authors who have published 4605 publications receiving 209938 citations.
Topics: Population, Health care, Veterans Affairs, Poison control, Mental health
Papers published on a yearly basis
Papers
More filters
••
TL;DR: The top 4 barriers to increased consideration and use of pharmacotherapy for alcohol dependence were consistent across high- and low-adopting facilities and included perceived low patient demand, pharmacy procedures or formulary restrictions, lack of provider skills or knowledge regarding pharmacotherapy, and lack of confidence in treatment effectiveness.
Abstract: Although access to and consideration of pharmacological treatments for alcohol dependence are consensus standards of care, receipt of these medications by patients is generally rare and highly variable across treatment settings. The goal of the present project was to survey and interview the clinicians, managers, and pharmacists affiliated with addiction treatment programs within Veterans Health Administration (VHA) facilities to learn about their perceptions of barriers and facilitators regarding greater and more reliable consideration of pharmacological treatments for alcohol dependence. Fifty-nine participants from 19 high-adopting and 11 low-adopting facilities completed the survey (facility-level response rate = 50%) and 23 participated in a structured interview. The top 4 barriers to increased consideration and use of pharmacotherapy for alcohol dependence were consistent across high- and low-adopting facilities and included perceived low patient demand, pharmacy procedures or formulary restrictions, lack of provider skills or knowledge regarding pharmacotherapy for alcohol dependence, and lack of confidence in treatment effectiveness. Low patient demand was rated as the most important barrier for oral naltrexone and disulfiram, whereas pharmacy or formulary restrictions were rated as the most important barrier for acamprosate and extended-release naltrexone. The 4 strategies rated across low- and high-adopting facilities as most likely to facilitate consideration and use of pharmacotherapy for alcohol dependence were more education to patients about existing medications, more education to health care providers about medications, increased involvement of physicians in treatment for alcohol dependence, and more compelling research on existing medications. This knowledge provides a foundation for designing, deploying, and evaluating targeted implementation efforts.
68 citations
••
TL;DR: The scientific quality of submitted manuscripts would increase if researchers addressed common design, analytical, and reporting issues that are most frequently found in manuscripts.
Abstract: Background: To assist educators and researchers in improving the quality of medical research, we surveyed the editors and statistical reviewers of high-impact medical journals to ascertain the most frequent and critical statistical errors in submitted manuscripts. Findings: The Editors-in-Chief and statistical reviewers of the 38 medical journals with the highest impact factor in the 2007 Science Journal Citation Report and the 2007 Social Science Journal Citation Report were invited to complete an online survey about the statistical and design problems they most frequently found in manuscripts. Content analysis of the responses identified major issues. Editors and statistical reviewers (n = 25) from 20 journals responded. Respondents described problems that we classified into two, broad themes: A. statistical and sampling issues and B. inadequate reporting clarity or completeness. Problems included in the first theme were (1) inappropriate or incomplete analysis, including violations of model assumptions and analysis errors, (2) uninformed use of propensity scores, (3) failing to account for clustering in data analysis, (4) improperly addressing missing data, and (5) power/sample size concerns. Issues subsumed under the second theme were (1) Inadequate description of the methods and analysis and (2) Misstatement of results, including undue emphasis on p-values and incorrect inferences and interpretations. Conclusions: The scientific quality of submitted manuscripts would increase if researchers addressed these common design, analytical, and reporting issues. Improving the application and presentation of quantitative methods in scholarly manuscripts is essential to advancing medical research.
68 citations
••
TL;DR: Participation in a voluntary community kidney disease screening and education program was associated with higher rates of ESRD preparation and survival and a lower risk for mortality.
68 citations
••
TL;DR: A new clinical definition of EALI may have value in identifying patients with ALI early in their disease course, and is associated with immunosuppression, the modified Rapid Emergency Medicine Score, airspace opacities beyond the bases, systemic inflammatory response syndrome, and the initial oxygen requirement.
68 citations
••
TL;DR: The results show that patellofemoral pain may be related to bone metabolic activity at the patella and trochlea, and increased tracer uptake in 85% of the painful knees examined was detected.
68 citations
Authors
Showing all 2575 results
Name | H-index | Papers | Citations |
---|---|---|---|
Gregg C. Fonarow | 161 | 1676 | 126516 |
Jongmin Lee | 150 | 2257 | 134772 |
Roger J. Davis | 147 | 498 | 103478 |
Eugene C. Butcher | 146 | 446 | 72849 |
Gerald M. Reaven | 133 | 799 | 80351 |
Paul G. Shekelle | 132 | 601 | 101639 |
Helena C. Kraemer | 132 | 562 | 65755 |
Glenn M. Chertow | 128 | 764 | 82401 |
Lawrence Steinman | 119 | 639 | 55583 |
Rudolf H. Moos | 119 | 622 | 49816 |
Cornelia M. Weyand | 116 | 460 | 44948 |
Jiahuai Han | 111 | 379 | 49379 |
Jörg J. Goronzy | 111 | 420 | 37634 |
Adolf Pfefferbaum | 109 | 530 | 40358 |
Michael F. Green | 106 | 485 | 45707 |